MedPath

Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment

Not Applicable
Completed
Conditions
Cognitive Impairment
Aging
Interventions
Other: Overground Walking
Registration Number
NCT06029920
Lead Sponsor
Universitas Padjadjaran
Brief Summary

The purpose of this research is to investigate the impact of overground walking as a part of a rehabilitation program on the increase in Brain-derived neurotrophic factor (BDNF) levels, decrease in IL-6 levels, decrease in hs-CRP levels, improvement in cognitive function, and enhancement of quality of life (QOL) in older people with mild cognitive impairment. These findings are anticipated to contribute to the efforts to elevate BDNF levels, cognitive function, and QOL while reducing IL-6 and hsCRP levels in the elderly with mild cognitive impairment.

Detailed Description

This research employs a quasi-experimental research design using a Pretest-Posttest Design approach. The Pretest-Posttest method is executed by assessing before and after the intervention within the same group.

All research subjects receive the same treatment, which involves participating in an overground walking program on a flat surface. The selected research subjects are provided with an explanation of the research's objectives and benefits and the exercise and examination procedures, then sign the informed consent.

Research subjects are instructed to walk on a flat surface for a distance of 15 meters, with a duration of 20 minutes, increasing by 5 minutes each week until the target heart rate is achieved during the exercise. After an 8-week post-intervention period, research subjects will undergo a follow-up examination.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Mild cognitive impairment (MoCA INA Score 19-25 out of 30
  • Barthel Index Score 20
  • Geriatric Depression Scale Score ≤ 5
  • Timed Up and Go Test < 15 seconds)
  • Capable of comprehending verbal and written instructions
  • Capable of walking unassisted
Exclusion Criteria
  • The presence of hearing impairment that could hinder the subject from receiving verbal instructions,
  • The presence of uncorrected visual impairment
  • Having musculoskeletal disorders
  • Receiving other rehabilitation programs,
  • Presence of diseases causing cognitive impairment
  • Severe joint diseases such as osteoarthritis and rheumatoid arthritis that may worsen during exercise or could pose difficulties in carrying out the exercise program,
  • Severe cardiovascular diseases as diagnosed by a Cardiologist

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SubjectsOverground Walking-
Primary Outcome Measures
NameTimeMethod
ADQOL8 weeks

Alzheimer disease Quality of Life

hsCRP8 weeks

hs-CRP level

BDNF8 weeks

Brain-derived neurotrophic factor level

IL68 weeks

Interleukin-6 level

MoCAINA8 weeks

MONTREAL COGNITIVE ASSESSMENT INDONESIA

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nursing Home

🇮🇩

Bandung, Jawa Barat, Indonesia

© Copyright 2025. All Rights Reserved by MedPath